Richmond Pharmacology appoints Priscilla Ochuba as associate medical director
Ella Day | August 1, 2025 | Appointment | Research and Development | Contract Research Organsation, Corporate, Pharmacy, Richmond Pharmacology, associate medical director
Richmond Pharmacology has announced the promotion of Priscilla Ochuba to associate medical director, effective 1 August 2025. The move recognises her outstanding contributions to early-phase research and leadership within the organisation’s medical directorate.
Ochuba joined Richmond in 2022 with a background in general medicine and has since become an integral figure in the delivery of complex early-phase trials involving both healthy volunteers and patient populations. Her approach to clinical safety, scientific rigour and trial execution has consistently supported successful research outcomes.
Commenting on her appointment, Ochuba said: “I’m honoured to take on the role of associate medical director. My time at Richmond has allowed me to contribute to clinical research that directly impacts patient care. I look forward to continuing to support our teams as we advance innovative approaches in trial design and delivery.”
Ulrike Lorch, chief medical director, added: “We are very pleased to acknowledge Ochuba’s promotion, a reflection of her deep commitment to clinical excellence and the integrity of our research. Her measured and thoughtful leadership, combined with a collaborative approach, continues to strengthen our medical directorate.”
Based in London, UK, Richmond Pharmacology is a contract research organisation (CRO) specialising in early-phase clinical trials. The company conducts studies involving healthy volunteers and patient populations to assess the safety and pharmacology of new medicines before they progress to later-stage development.
Ella Day
1/8/25
This article featured in: September 2025 – The Pharmafile Brief
Related Content
Confronting the ‘danger’ of blocking progress on clinical trial transparency
The Ethical Medicines Industry Group and Sense About Science – a co-founder of the ALLTrials …
HRA must continue ‘progress towards clinical trial transparency’
Campaigners and industry leaders have urged the Health Research Authority to ensure that its work …
Judge rules pharma has ‘ethical’ transparency obligation – reaction
Both sides of a bitterly contested legal battle over a major part of the industry’s …
